Vgi Partners Asian
- Short interest
- 0.00%
- +0.02 pp 30d
- as of 17 June 2026
- Reported shorts
- 55
- Shares on issue
- 215.534M
Vgi Partners Asian (VFY) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXChange to CEO Remuneration and Employment Terms
other announcement
KalkineWhy is Vitrafy Life Sciences back in focus after its new US blood network partnership?
Highlights Vitrafy Life Sciences has expanded its platelet cryopreservation program through a new collaboration with US non-profit blood network Versiti Blood Health. The work follows a US Army Institute of Surgical Research study that recorded strong post-thaw platelet recovery using Vitrafys technology. The collaboration is intended to support verification and validation work ahead of the companys planned US medical device listing. Vitrafy Life Sciences (ASX:VFY) has widened the reach of it...
Small CapsVitrafy Life Sciences Expands Platelet Cryopreservation Program With Versiti Blood Health
Vitrafy Life Sciences expands platelet cryopreservation with Versiti; 94.4% post-thaw recovery from USAISR, two free units, US device listing aimed FY2027.
Vitrafy enters partnership with Versiti Blood Health
other announcement
Vitrafy enters U.S. Cell & Gene Therapy Market
other announcement
Google NewsVitrafy Life Sciences (ASX:VFY) Shares Rise as Investors Track Biotech Development Landscape - Kalkine
Vitrafy Life Sciences (ASX:VFY) Shares Rise as Investors Track Biotech Development Landscape Kalkine
Vitrafy Life Sciences (ASX: VFY): Cryo Stock in Focus - Kalkine
Vitrafy Life Sciences (ASX: VFY): Cryo Stock in Focus Kalkine
Q4 FY26 Quarterly Activities Report and Appendix 4C
other announcement
Vitrafy (ASX:VFY) Shares Leap 15.7% on Hoxworth Blood Center Partnership in the US - Kalkine
Vitrafy (ASX:VFY) Shares Leap 15.7% on Hoxworth Blood Center Partnership in the US Kalkine
StockheadHealth Check: Vitrafy addresses looming US platelet shortage with US blood bank collab
Cryopreserver Vitrafy has entered a partnership with the oldest blood bank in the US to reduce platelet wastage with better ... Read More The post Health Check: Vitrafy addresses looming US platelet shortage with US blood bank collab appeared first on Stockhead.
Vitrafy enters a partnership with Hoxworth Blood Center
other announcement
Vitrafy Life Sciences (ASX:VFY) Drops as Med-Tech Volatility Returns - Kalkine
Vitrafy Life Sciences (ASX:VFY) Drops as Med-Tech Volatility Returns Kalkine
Change of Director's Interest Notice - Correction
director_dealing announcement
Results of Oversubscribed Share Purchase Plan
capital_raise announcement
Why Vitrafy Life Sciences (ASX:VFY) Is Under Pressure as Commercialisation Remains the Key Test - Kalkine
Why Vitrafy Life Sciences (ASX:VFY) Is Under Pressure as Commercialisation Remains the Key Test Kalkine
Vitrafy Life Sciences (ASX:VFY) Slides Today as Healthcare Stock Faces Pressure - Kalkine
Vitrafy Life Sciences (ASX:VFY) Slides Today as Healthcare Stock Faces Pressure Kalkine
Could Recent Developments Drive Vitrafy Life Sciences (ASX: VFY) Shares Higher? - Kalkine
Could Recent Developments Drive Vitrafy Life Sciences (ASX: VFY) Shares Higher? Kalkine
Vitrafy Share Purchase Plan Opens - SPP Offer Booklet
capital_raise announcement
Vitrafy’s Big Raise: Can This Small Cap Crack The US?
Highlights Vitrafy Life Sciences has secured fresh capital to support its Guardion device roll-out and United States expansion. The raise places renewed attention on emerging healthcare companies seeking scale through commercial milestones. Small-cap capital events remain important signals for growth plans, funding needs and execution risk. Vitrafy Life Sciences is drawing attention after securing fresh capital to fund Guardion inventory, United States expansion and working capital needs. Aus...
Vitrafy (ASX:VFY) raises A$30m at a 31.6% discount to chase 2027 - Stocks Down Under
Vitrafy (ASX:VFY) raises A$30m at a 31.6% discount to chase 2027 Stocks Down Under
Vitrafy Placement Completion and SPP Announcement
capital_raise announcement
Vitrafy Life Sciences (ASX:VFY) Shares Gain After Key U.S. Healthcare Collaboration - Kalkine
Vitrafy Life Sciences (ASX:VFY) Shares Gain After Key U.S. Healthcare Collaboration Kalkine
Vitrafy enters a partnership with Vitalant Innovation Center
other announcement
Vitrafy Life Sciences (ASX:VFY) Shares Drop 6% Today- Here’s Why? - Kalkine
Vitrafy Life Sciences (ASX:VFY) Shares Drop 6% Today- Here’s Why? Kalkine
Q3 FY26 Quarterly Activities Report and Appendix 4C
other announcement
Vitrafy to present at NWR Virtual Healthcare Conference
other announcement
Q2 FY26 Quarterly Activities Report and Appendix 4C
other announcement